1. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4

   • C. M. Forsblom
   • T. Sane
   • L. Groop

   Originals Pages: 1253 - 1262

2. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups

   • J. Cabezas-Cerrato
   • The Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS)

   Originals Pages: 1263 - 1269

3. Effect of intensive glycaemic control on fibrinogen plasma concentrations in patients with Type II diabetes mellitus. Relation with β-fibrinogen genotype

   • A. Ceriello
   • F. Mercuri
   • G. Damante

   Originals Pages: 1270 - 1273

4. Risk factors of severe hypoglycaemia in adult patients with Type I diabetes – a prospective population based study

   • I. Mühlhauser
   • H. Overmann
   • M. Berger

   Originals Pages: 1274 - 1282

5. Influence of laser photocoagulation for clinically significant diabetic macular oedema (DMO) on short-wavelength and conventional automated perimetry

   • C. Hudson
   • J. G. Flanagan
   • D. McLeod

   Originals Pages: 1283 - 1292

6. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children

   • K. Savola
   • E. Sabbah
   • M. Knip

   Originals Pages: 1293 - 1297

7. Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes

   • S. Martin
   • E. Heidenthal
   • H. Kolb

   Originals Pages: 1298 - 1303

8. The C825T polymorphism in the human G-protein β3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus

   • D. G. Fogarty
   • M. J. Zychma
   • A. S. Krolewski

   Originals Pages: 1304 - 1308

9. The ageing entero-insular axis

   • L. Ranganath
   • I. Sedgwick
   • V. Marks

   Originals Pages: 1309 - 1313

10. Bone mineral density, collagen type 1 α 1 genotypes and bone turnover in premenopausal women with diabetes mellitus

    • G. Hampson
    • C. Evans
    • S. H. Ralston

    Originals Pages: 1314 - 1320

11. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats

    • X. Qiang
    • J. Satoh
    • T. Toyota

    Originals Pages: 1321 - 1326

12. Evidence for direct action of alloxan to induce insulin resistance at the cellular level

    • M. Ader
    • J. M. Richey
    • R. N. Bergman

    Originals Pages: 1327 - 1336

13. Maternal low protein diet in rats programmes fatty acid desaturase activities in the offspring

    • S. E. Ozanne
    • N. D. Martensz
    • C. N. Hales

    Originals Pages: 1337 - 1342

14. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway

    • J. R. Zierath
    • J. N. Livingston
    • Peter Arner

    Originals Pages: 1343 - 1354

15. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes

    • T. Sano
    • F. Umeda
    • H. Utsumi

    Originals Pages: 1355 - 1360

16. Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats

    • R. Vettor
    • C. Pagano
    • B. Jeanrenaud

    Originals Pages: 1361 - 1367

17. Preserved initiatory and potentiatory effect of α-ketoisocaproate on insulin release in islets of glucose intolerant rats

    • A. Guenifi
    • S. M. Abdel-Halim
    • C.-G. Östenson

    Originals Pages: 1368 - 1373

18. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice

    • B. Ahrén
    • C. Oosterwijk
    • J. W. M. Höppener

    Originals Pages: 1374 - 1380

19. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes

    • P. Augstein
    • A. G. Elefanty
    • L. C. Harrison

    Originals Pages: 1381 - 1388

20. Mapping of the human insulin receptor substrate-2 gene, identification of a linked polymorphic marker and linkage analysis in families with Type II diabetes: no evidence for a major susceptibility role

    • K. Kalidas
    • J. Wasson
    • M. Alan Permutt

    Short communication Pages: 1389 - 1391

21. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes

    • G. De Mattia
    • M. C. Bravi
    • C. Ferri

    Short communication Pages: 1392 - 1396

22. Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypes

    Letters to the editor Pages: 1397 - 1398

23. Synergic effect of polymorphisms in uncoupling protein 1 and β3-adrenergic receptor genes on weight loss in obese Japanese

    Letters to the editor Pages: 1399 - 1399